Literature DB >> 28042221

Emergence of Aeromonas spp. Harboring Multiple Carbapenemase-encoding Genes from Hospital Sewage.

Tuhina Banerjee1, Sourav Pal1, Arghya Das1.   

Abstract

Entities:  

Year:  2017        PMID: 28042221      PMCID: PMC5015503          DOI: 10.4103/0974-2727.187924

Source DB:  PubMed          Journal:  J Lab Physicians        ISSN: 0974-2727


× No keyword cloud information.
Sir, In January 2016 issue of the journal, an excellent review on Aeromonas spp.[1] as an emerging pathogen has been published emphasizing the importance of this enteric pathogen. We have also recently experienced the increasing prevalence of this organism in our hospital environment. A study was carried out to determine the prevalence of various enteric pathogens in hospital sewage of a tertiary care center in Varanasi, North India. Samples from 22 different sites were collected as previously described,[2] and sewage samples were processed by membrane filtration method. Colonies of Aeromonas spp. were isolated on MacConkey agar and isolates were biochemically identified[2] and type species were confirmed by 16sRNA-based polymerase chain reaction (PCR) and sequencing. Antimicrobial susceptibility testing was performed as per the Clinical and Laboratory Standards Institute[3] and isolates were screened for the presence of carbapenemase genes by PCR (blaGES, blaIMI/ NMC-A, blaSME, blaKPC, blaIMP, blaVIM, blaOXA-48, blaNDM).[4] A total of seven Aeromonas isolates were identified from seven different sites comprising four isolates of Aeromonas caviae and three isolates of Aeromonas hydrophila. The antimicrobial resistance profile of the isolates was 28.57% resistance to cefuroxime, 28.57% to ceftriaxone, 28.57% to cefepime, and 42.85% to levofloxacin. All except one (No.A) isolate were susceptible to carbapenems, namely, imipenem and meropenem by disc diffusion method. However, this isolate No.A harbored the blaNDM-1 and blaOXA-48 along with blaGES carbapenemase genes [Figure 1].
Figure 1

Polymerase chain reaction amplification of carbapenemase-encoding genes

Polymerase chain reaction amplification of carbapenemase-encoding genes It has been stated that the carriage rate of Aeromonas in human gut varies from 0% to 4%.[1] However, their increased isolation in hospital effluents which provides an excellent media for genetic exchange, being enriched with selective antibiotic pressure, is a threat to their emergence as virulent enteric pathogens. A few reports of bla-positive Aeromonas carriage in stool have been recently reported.[56] In this case, isolate-harboring multiple carbapenemase-encoding genes simply accelerate the evolution of antimicrobial resistance in these pathogens.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Multiplex PCR for detection of acquired carbapenemase genes.

Authors:  Laurent Poirel; Timothy R Walsh; Vincent Cuvillier; Patrice Nordmann
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-12       Impact factor: 2.803

2.  The route of antimicrobial resistance from the hospital effluent to the environment: focus on the occurrence of KPC-producing Aeromonas spp. and Enterobacteriaceae in sewage.

Authors:  Renata C Picão; Juliana P Cardoso; Eloiza H Campana; Adriana G Nicoletti; Fernanda V B Petrolini; Diego M Assis; Luiz Juliano; Ana C Gales
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-09       Impact factor: 2.803

3.  Distribution and survival of motile Aeromonas spp. in brackish water receiving sewage treatment effluent.

Authors:  P Monfort; B Baleux
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

Review 4.  Aeromonas spp.: An Emerging Nosocomial Pathogen.

Authors:  Priyam Batra; Purva Mathur; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2016 Jan-Jun
  4 in total
  1 in total

1.  Application of Modified Carbapenem Inactivation Method and Its Derivative Tests for the Detection of Carbapenemase-Producing Aeromonas.

Authors:  Yunying Wang; Hui Liu; Lijun Zhang; Bin Sun
Journal:  Infect Drug Resist       Date:  2021-09-24       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.